|
1
|
Catterall WA: The molecular basis of
neuronal excitability. Science. 223:653–661. 1984.
|
|
2
|
Catterall WA: From ionic currents to
molecular mechanisms: the structure and function of voltage-gated
sodium channels. Neuron. 26:13–25. 2000.
|
|
3
|
Antzelevitch C, Brugada P, Borggrefe M, et
al: Brugada syndrome: report of the second consensus conference:
endorsed by the Heart Rhythm Society and the European Heart Rhythm
Association. Circulation. 111:659–670. 2005.
|
|
4
|
Veltmann C, Schimpf R, Echternach C, et
al: A prospective study on spontaneous fluctuations between
diagnostic and non-diagnostic ECGs in Brugada syndrome:
implications for correct phenotyping and risk stratification. Eur
Heart J. 27:2544–2552. 2006.
|
|
5
|
Bennett PB, Yazawa K, Makita N and George
AL Jr: Molecular mechanism for an inherited cardiac arrhythmia.
Nature. 376:683–685. 1995.
|
|
6
|
Waxman SG: Painful Na-channelopathies: an
expanding universe. Trends Mol Med. 19:406–409
|
|
7
|
Oliva M, Berkovic SF and Petrou S: Sodium
channels and the neurobiology of epilepsy. Epilepsia. 53:1849–1859.
2012.
|
|
8
|
Brackenbury WJ: Voltage-gated sodium
channels and metastatic disease. Channels (Austin). 6:352–361.
2012.
|
|
9
|
Baade PD, Youlden DR and Krnjacki LJ:
International epidemiology of prostate cancer: geographical
distribution and secular trends. Mol Nutr Food Res. 53:171–184.
2009.
|
|
10
|
Diss JK, Stewart D, Pani F, et al: A
potential novel marker for human prostate cancer: voltage-gated
sodium channel expression in vivo. Prostate Cancer Prostatic Dis.
8:266–273. 2005.
|
|
11
|
Diss JK, Fraser SP, Walker MM, Patel A,
Latchman DS and Djamgoz MB: Beta-subunits of voltage-gated sodium
channels in human prostate cancer: quantitative in vitro and in
vivo analyses of mRNA expression. Prostate Cancer Prostatic Dis.
11:325–333. 2008.
|
|
12
|
Laniado ME, Lalani EN, Fraser SP, et al:
Expression and functional analysis of voltage-activated
Na+ channels in human prostate cancer cell lines and
their contribution to invasion in vitro. Am J Pathol.
150:1213–1221. 1997.
|
|
13
|
Grimes JA, Fraser SP, Stephens GJ, et al:
Differential expression of voltage-activated Na+
currents in two prostatic tumour cell lines: contribution to
invasiveness in vitro. FEBS Lett. 369:290–294. 1995.
|
|
14
|
Nguyen TP, Wang DW, Rhodes TH and George
AL Jr: Divergent biophysical defects caused by mutant sodium
channels in dilated cardiomyopathy with arrhythmia. Circ Res.
102:364–371. 2008.
|
|
15
|
Benson DW, Wang DW, Dyment M, et al:
Congenital sick sinus syndrome caused by recessive mutations in the
cardiac sodium channel gene (SCN5A). J Clin Invest. 112:1019–1028.
2003.
|
|
16
|
Sato PY, Musa H, Coombs W, et al: Loss of
plakophilin-2 expression leads to decreased sodium current and
slower conduction velocity in cultured cardiac myocytes. Circ Res.
105:523–526. 2009.
|
|
17
|
Wang C, Hennessey JA, Kirkton RD, et al:
Fibroblast growth factor homologous factor 13 regulates
Na+ channels and conduction velocity in murine hearts.
Circ Res. 109:775–782. 2011.
|
|
18
|
Nomiya T, Tsuji H, Toyama S, et al:
Management of high-risk prostate cancer: radiation therapy and
hormonal therapy. Cancer Treat Rev. 39:872–878. 2013.
|
|
19
|
Diaz D, Delgadillo DM, Hernández-Gallegos
E, et al: Functional expression of voltage-gated sodium channels in
primary cultures of human cervical cancer. J Cell Physiol.
210:469–478. 2007.
|
|
20
|
Fraser SP, Diss JK, Chioni AM, et al:
Voltage-gated sodium channel expression and potentiation of human
breast cancer metastasis. Clin Cancer Res. 11:5381–5389. 2005.
|
|
21
|
Hernandez-Plata E, Ortiz CS,
Marquina-Castillo B, et al: Overexpression of NaV 1.6 channels is
associated with the invasion capacity of human cervical cancer. Int
J Cancer. 130:2013–2023. 2012.
|
|
22
|
Roger S, Besson P and Le Guennec JY:
Involvement of a novel fast inward sodium current in the invasion
capacity of a breast cancer cell line. Biochim Biophys Acta.
1616:107–111. 2003.
|
|
23
|
Fraser SP, Grimes JA and Djamgoz MB:
Effects of voltage-gated ion channel modulators on rat prostatic
cancer cell proliferation: comparison of strongly and weakly
metastatic cell lines. Prostate. 44:61–76. 2000.
|
|
24
|
Abdul M and Hoosein N: Voltage-gated
sodium ion channels in prostate cancer: expression and activity.
Anticancer Res. 22:1727–1730. 2002.
|
|
25
|
Smith P, Rhodes NP, Shortland AP, et al:
Sodium channel protein expression enhances the invasiveness of rat
and human prostate cancer cells. FEBS Lett. 423:19–24. 1998.
|
|
26
|
Brisson L, Gillet L, Calaghan S, et al:
Na(V)1.5 enhances breast cancer cell invasiveness by increasing
NHE1-dependent H(+) efflux in caveolae. Oncogene. 30:2070–2076.
2011.
|
|
27
|
Carrithers MD, Chatterjee G, Carrithers
LM, et al: Regulation of podosome formation in macrophages by a
splice variant of the sodium channel SCN8A. J Biol Chem.
284:8114–8126. 2009.
|
|
28
|
Diamandis EP and Yu H: Nonprostatic
sources of prostate-specific antigen. Urol Clin North Am.
24:275–282. 1997.
|
|
29
|
Foster CS, Cornford P, Forsyth L, Djamgoz
MB and Ke Y: The cellular and molecular basis of prostate cancer.
BJU Int. 83:171–194. 1999.
|
|
30
|
de Kok JB, Verhaegh GW, Roelofs RW, et al:
DD3 (PCA3), a very sensitive and specific marker to detect prostate
tumors. Cancer Res. 62:2695–2698. 2002.
|
|
31
|
Chakravarti A and Zhai GG: Molecular and
genetic prognostic factors of prostate cancer. World J Urol.
21:265–274. 2003.
|
|
32
|
Biki B, Mascha E, Moriarty DC, Fitzpatrick
JM, Sessler DI and Buggy DJ: Anesthetic technique for radical
prostatectomy surgery affects cancer recurrence: a retrospective
analysis. Anesthesiology. 109:180–187. 2008.
|
